clinicalomicsprowebdirectory
Facebook
Linkedin
Twitter
News
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Search
Facebook
Linkedin
Twitter
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Privacy Policy
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Inside Precision Medicine
News
News & Features
AI Models Outperformed Human Experts in Detecting Ovarian Cancer on Ultrasound
Informatics
Large-Scale Genomic Analysis Improves Outcomes in 20 Cancer Types
News & Features
New Genetic Variants May Help Explain Why More Boys Get Autism
News & Features
Machine Learning Uncovers Osteosarcoma Subtypes, Paving the Way for Personalized Medicine
Informatics
AI Crunches Clinical Notes to Highlight Care Improvement Opportunities
Topics
Informatics
Molecular Dx
Patient Care
Oncology
Precision Medicine
Translational Research
Magazine
Browse Issues
Subscribe
Marketplace
Translational Research
Molecular Diagnostics
Oncology/Therapeutics
Healthcare Informatics
Subscribe
Get Inside Precision Medicine Magazine
Get Inside Precision Medicine eNewsletters
Multimedia
eBooks
Webinars
Summits
Learning Labs
Podcasts
Inside Precision Medicine Live
Inside Precision Medicine
CVS Enters Precision Health Arena with Transform Oncology Care Launch
Medicare
Molecular Dx
CVS Enters Precision Health Arena with Transform Oncology Care Launch
December 13, 2019
0
Molecular Dx
UTC/RenRX, 3 Principals Agree to Pay $42.6M to Settle False Claims Allegations
October 10, 2019
0
Molecular Dx
CareDx Gets Medicare Draft Coverage Decision for Heart Transplant Rejection Test
August 23, 2019
0
Molecular Dx
Myriad Genetics Gets Medicare Coverage for myPath Melanoma Test
March 14, 2019
0
Molecular Dx
GenomeDx to Pay $1.99M to Settle Medicare Billing Allegations
February 12, 2019
0
Molecular Dx
Stakeholders Urge CMS to Revise NCD Interpretation for NGS Tests
February 1, 2019
0
Molecular Dx
Epic Sciences, Four Canadian Breast Cancer Centers Launch Trial of Blood Test
November 5, 2018
0
Molecular Dx
Breaking NGS Ground
Alex Philippidis
May 21, 2018
0
News & Features
Palmetto GBA Recommends Coverage of Epic/Genome Health Prostate Cancer Test
March 30, 2018
0
Molecular Dx
FoundationOne CDx Wins National Coverage Decision Across All Solid Tumors
March 19, 2018
0
1
2
3
4
Page 3 of 4
Related Content
Machine Learning Uncovers Osteosarcoma Subtypes, Paving the Way for Personalized Medicine
Genetic Testing Improves Diagnosis of Children with Neurodevelopmental Disorders
Potential Action: SiteOne’s $100M Series C to Advance Non-Opioid Pain Drugs
Not All Precision Medicine Heroes Wear Lab Coats
Inside Precision Medicine
![A final National Coverage Determination (NCD) of the Centers for Medicare & Medicaid Services allows Medicare and Medicare Advantage patients to be reimbursed for next generation sequencing (NGS) testing across all solid tumors with Foundation Medicine’s FoundationOne CDx comprehensive genomic profiling assay. [Foundation Medicine]](https://www.insideprecisionmedicine.com/wp-content/uploads/2019/01/1541-768x576.png "FoundationOne CDx Wins National Coverage Decision Across All Solid Tumors")
